Sunshine Biopharma is trading at $2.81, up 6.04% after hours on November 4, 2026, with no verified company-specific announcement explaining the move.
- The company’s press-release page lists its October 22 reverse-split announcement as its latest release; TheFly also shows no newer company news.
- Supplied market context is mixed and does not establish a broad-market explanation for the gain.